Recent News Releases
Latest News Releases
CSL to Move Global Headquarters
Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination
CSL Renews Partnership with NYSF
MELBOURNE, Australia - CSL today announced its continued partnership with the National Youth Science Forum (NYSF) signing a new three-year agreement in support of programs that encourage life-long STEM literacy.
CSL at J.P. Morgan's 2019 Healthcare Conference
CSL Limited today announced that it will present at the 2019 J.P. Morgan Annual Healthcare Conference. CEO and Managing Director Paul Perreault will present the company’s overview on Wednesday, January 9 at 8:30 a.m. Pacific time.
Nancy Millis building opens at Bio21 Institute
The Honourable John Brumby AO today formally opened the new ‘Nancy Millis’ building, an expansion of the Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, incorporating CSL’s Global Hub for Research and Translational Medicine.
Developments in cell-based vaccine technology
CSL spotlights developments in cell-based vaccine technology at Australian Research and Development briefing
2019 Centenary Fellowship Winners Announced
Two Australian scientists have each been awarded an AUD$1.25 million, five-year, CSL Centenary Fellowship to further research into why so many people die from infection following stroke and how we might develop better vaccines against diseases such as tuberculosis.
Senior Manager, Communications
Phone: +61 429 609 762